Article Details

Immunomedics, Inc. (NASDAQ:IMMU) Receives Average Rating of "Buy" from Analysts

Retrieved on: 2020-08-22 21:41:15

Tags for this article:

Click the tags to see associated articles and topics

Immunomedics, Inc. (NASDAQ:IMMU) Receives Average Rating of "Buy" from Analysts. View article details on hiswai:

Excerpt

<div><b>AQR Capital Management</b> LLC now owns 135,027 shares of the biopharmaceutical company's stock valued at $4,785,000 after purchasing an ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up